Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-18 5:35 pm Unchanged | 13G | Harpoon Therapeutics Inc. HARP | GLAZER CAPITAL LLC | 0 0.000% | 0 (Unchanged) | View |
| 2024-03-13 4:14 pm Sale | 13D | Harpoon Therapeutics Inc. HARP | GAMCO INVESTORS INC. GBL | 0 0.000% | -862,549 (Position Closed) | View |
| 2024-03-11 3:19 pm Sale | 13D | Harpoon Therapeutics Inc. HARP | MERCK SHARP & DOHME CORP. MRK | 1,000 100.000% | -3,079,815 (-99.97%) | View |
| 2024-02-27 4:02 pm Purchase | 13D | Harpoon Therapeutics Inc. HARP | GAMCO INVESTORS INC. GBL | 862,549 4.030% | 862,549 (New Position) | View |
| 2024-02-21 4:43 pm Sale | 13D | Harpoon Therapeutics Inc. HARP | Arix Bioscience plc | 323,893 1.500% | -2,915,036 (-90.00%) | View |
| 2024-02-14 6:18 pm Sale | 13G | Harpoon Therapeutics Inc. HARP | CITADEL ADVISORS LLC | 1,027,956 6.000% | -3 (-0.00%) | View |
| 2024-02-14 5:01 pm Purchase | 13G | Harpoon Therapeutics Inc. HARP | RA CAPITAL MANAGEMENT L.P. | 1,712,792 9.990% | 11,222 (+0.66%) | View |
| 2024-02-13 9:04 pm Sale | 13G | Harpoon Therapeutics Inc. HARP | New Leaf Ventures III L.P. | 5,643,788 11.000% | -604,681 (-9.68%) | View |
| 2024-02-13 5:06 pm Purchase | 13G | Harpoon Therapeutics Inc. HARP | VANGUARD GROUP INC | 880,017 5.200% | 880,017 (New Position) | View |
| 2024-02-12 4:09 pm Purchase | 13D | Harpoon Therapeutics Inc. HARP | MPM BioVentures 2014 L.P. | 663,806 3.700% | 663,806 (New Position) | View |
| 2024-02-09 5:09 pm Sale | 13G | Harpoon Therapeutics Inc. HARP | Artal International S.C.A. | 2,038,870 9.900% | -308,567 (-13.14%) | View |
| 2024-02-06 4:15 pm Sale | 13G | Harpoon Therapeutics Inc. HARP | Soleus Private Equity Fund III L.P. | 1,820,365 9.990% | -47,690 (-2.55%) | View |
| 2024-01-19 4:19 pm Purchase | 13G | Harpoon Therapeutics Inc. HARP | INTEGRATED CORE STRATEGIES (US) LLC | 25,465 0.200% | 25,465 (New Position) | View |
| 2024-01-17 5:48 pm Purchase | 13D | Harpoon Therapeutics Inc. HARP | MERCK SHARP & DOHME CORP. MRK | 3,080,815 17.480% | 3,080,815 (New Position) | View |
| 2023-11-06 4:34 pm Purchase | 13G | Harpoon Therapeutics Inc. HARP | CITADEL ADVISORS LLC | 1,027,959 6.000% | 1,027,959 (New Position) | View |
| 2023-11-06 4:31 pm Purchase | 13G | Harpoon Therapeutics Inc. HARP | RA CAPITAL MANAGEMENT L.P. | 1,701,570 9.990% | 1,701,570 (New Position) | View |
| 2023-11-06 4:01 pm Purchase | 13G | Harpoon Therapeutics Inc. HARP | Cormorant Asset Management LP | 1,678,619 9.900% | 1,678,619 (New Position) | View |
| 2023-11-03 4:05 pm Purchase | 13G | Harpoon Therapeutics Inc. HARP | COMMODORE CAPITAL LP | 1,703,465 9.900% | 1,703,465 (New Position) | View |
| 2023-10-26 5:00 pm Purchase | 13G | Harpoon Therapeutics Inc. HARP | Soleus Private Equity Fund III L.P. | 1,868,055 9.990% | 1,868,055 (New Position) | View |
| 2023-03-31 4:15 pm Purchase | 13G | Harpoon Therapeutics Inc. HARP | Artal International S.C.A. | 2,347,437 6.100% | 2,347,437 (New Position) | View |